ARIAD Pharma (ARIA) on Watch After Filing Form 10-Q
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
ARIAD Pharma (NASDAQ: ARIA) was on watch after filing form 10-Q with the SEC:
From the filing:
In October 2016, we received a letter from Rep. Elijah Cummings and Sen. Bernard Sanders requesting information and supporting documentation from us related to Iclusig and the pricing of Iclusig in the United States since 2012. The letter inquired about our approach to pricing, commercialization and related matters for Iclusig. We responded to the letter on November 4, 2016 and are cooperating with this inquiry.
In November 2016, we received a subpoena from the U.S. Attorney’s Office for the District of Massachusetts requesting documents related to our support of 501(c)(3) organizations that provide financial assistance to Medicare patients and our patient support programs. Other companies in our industry have disclosed similar inquiries. We intend to cooperate with this inquiry.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corvex Management Cuts Signet Jewelers (SIG) Stake in Half
- RGS Energy (RGSE) to Conduct Units Offering
- Deborah Wong Yang is a top contender to head SEC in Trump Admin. - NBC
Create E-mail Alert Related CategoriesCorporate News, Litigation
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!